u/Concused-Ninja

Thinking out loud here - if and when TLRY enters the US medical market, and using easy numbers of 120M shares, while factoring the additional shares being 20% of current shares, that will bring total share count to 144M shares.

If a big Pharma company wanted to take over TLRY at 51% or 73.44M shares at $5.41 a piece, that is a $397,310,400 investment. Which is not that bad?

A lower share price will attract big players, and my gut is that is why we are seeing this accross the market, not so much just TLRY.

Roast me, educate me, or make me happy, I don’t care. I’m not thinking short term.